SAN
DIEGO, Sept. 27, 2022 /PRNewswire/ -- Cue Health
Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today
announced that it has appointed Suzanne
Stone as its new Chief Commercial Officer. Stone brings over
25 years of experience building high- performing sales and
marketing organizations in rapidly growing biotech and medical
device companies, most recently at DexCom, Inc.
As Chief Commercial Officer, Stone will lead the execution and
acceleration of Cue's global commercial strategy while building
international sales and customer success teams. She will also be
responsible for the success of the company's global marketing
initiatives, including branding, advertising, and e-commerce.
"Suzanne is a well-established commercial leader with extensive
healthcare experience and an impressive track record of building
great teams," said Ayub Khattak,
Chairman and CEO of Cue Health. "We look forward to accelerating
our growth in our key customer categories and strengthening our
position as a leading healthcare technology company by delivering a
seamless and consistent brand experience under Suzanne's capable
leadership."
"In a short period of time, Cue has had a transformative impact
on the ways in which patients can partner with their healthcare
providers to proactively manage their health," said Stone. "I am
grateful for the opportunity to join Cue at this pivotal time and
look forward to further integrating its sales and marketing efforts
through an innovative new growth strategy."
Prior to joining Cue, Stone served as Senior Vice President of
U.S. Revenue at DexCom, Inc., a medical device company focused on
glucose monitoring systems, where she grew and oversaw nearly
$2 billion in revenue across sales,
customer service, enterprise, payor, and trade relations across the
U.S. market. Previously, Stone held a number of executive roles at
DexCom, including in sales, global commercial operations, and
financial planning. Before DexCom, Stone served for eight years at
MannKind Corporation, a biopharmaceutical company, in financial
planning, analysis, and accounting positions.
About Cue Health
Cue Health ( Nasdaq: HLTH) is a healthcare technology company
that makes it easy for individuals to access health information and
places diagnostic information at the center of care. Cue Health
enables people to manage their health through real-time,
actionable, and connected health information, offering individuals
and their healthcare providers easy access to lab-quality
diagnostics anywhere, anytime, in a device that fits in the palm of
the hand. Cue Health's first-of-its-kind COVID-19 test was the
first FDA-authorized molecular diagnostic test for at-home and
over-the-counter use without a prescription and physician
supervision. Outside the United
States, Cue Health has received the CE mark in the European
Union, Interim Order authorization from Health Canada, regulatory
approval from India's Central
Drugs Standard Control Organization, and PSAR authorization from
Singapore's Health Sciences
Authority. Cue was founded in 2010 and is headquartered in
San Diego. For more information,
please visit www.cuehealth.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cue-health-appoints-suzanne-stone-as-new-chief-commercial-officer-301633524.html
SOURCE Cue Health Inc.